Hematology and Oncology Patient Care & Clinical Programs

Extraordinary patient care is the number one priority of Penn's Division of Hematology and Oncology. Patients and their physicians choose Penn because:

• Penn hematologists/oncologists are part of multidisciplinary teams of physicians, nurses and support staff from across clinical services who work together to treat the whole patient with individualized treatment plans.
• Penn Hematology/Oncology is part of Penn's Abramson Cancer Center, a comprehensive cancer treatment cancer as designated by the National Cancer Institute and rated as "exceptional" in its most recent peer review.
• Penn's Cellular and Transplant Therapy Program is one of the oldest and largest programs in the country, performing the most procedures in the Philadelphia region.
• Penn's hematologists/oncologists are at the forefront of medicine, teaching the next generation of leaders, and developing promising treatment options for tomorrow.
• Penn has dedicated in-patient and out-patient hematology/oncology units staffed with nurses, nurse practitioners and physician assistants experienced in caring for patients with cancer and blood-related disorders.
• Penn hematologists/oncologists continue to investigate new treatments for cancer and blood-related disorders and bring these novel therapies directly to patients.

To learn more about our cancer programs, please visit Penn Medicine's Abramson Cancer Center.

Our clinical activities span 15 clinical areas and programs focused on specific malignancy, blood disorder or approach to oncology treatment.

Our Non cancer clinical program are listed below:

• Amyloidosis Program
• Benign Hematology
  • Classical (non Malignant Hematology Program)
  • Comprehensive Hemophilia and Thrombosis Program
  • Sickle Cell Anemia
  • Thalassemia
  • Bone Marrow Failure Program